Skip to content
Open access

Protective Effects of Luteolin Against Cisplatin‐Induced Hepatic and Renal Toxicity: Biochemical and Cellular Evidence

Aug 2026 · Journal of biochemical and molecular toxicology · Vol 40 · 0 citations · 72 references
Medicine

TL;DR

It is suggested that Luteolin may represent a promising adjunctive candidate for reducing Cisplatin‐associated toxicity while improving therapeutic responsiveness and in vitro antiproliferative activity.

Abstract

ABSTRACT Cisplatin is a widely used chemotherapeutic agent; however, its clinical utility is frequently limited by dose‐dependent adverse effects, particularly hepatotoxicity and nephrotoxicity. Luteolin, a naturally occurring flavonoid abundant in various medicinal plants, exhibits well‐documented antioxidant and anticancer activities. This study investigated whether Luteolin isolated from Pistacia terebinthus fruits could attenuate Cisplatin‐induced organ toxicity while enhancing its antiproliferative effects. For the in vivo experiments, 48 male Swiss albino mice (9–10 weeks old, 26–30 g) were randomly assigned to eight groups (n = 6/group): control, Cisplatin, Luteolin (25, 50, or 100 mg/kg), and Cisplatin plus Luteolin (25, 50, or 100 mg/kg). Cisplatin (10 mg/kg/day, intraperitoneally) and/or Luteolin (25–100 mg/kg/day, orally) were administered for 14 consecutive days. Serum biochemical parameters, oxidative stress markers, antioxidant enzyme activities, and tissue injury‐related biomarkers were evaluated in liver and kidney tissues. Cisplatin administration significantly increased serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and glucose levels, whereas co‐treatment with Luteolin markedly attenuated these alterations in a dose‐dependent manner. In addition, Luteolin restored Cisplatin‐induced disturbances in oxidative stress and antioxidant defense markers, including malondialdehyde (MDA), 8‐hydroxy‐2′‐deoxyguanosine (8‐OHdG), HSP70 levels, superoxide dismutase (SOD), glutathione (GSH), glutathione peroxidase (GPx), glutathione reductase (GR), and glutathione S‐transferase (GST) activities in liver and kidney tissues. To support the in vivo findings, in vitro antiproliferative assays were performed using Saos‐2 osteosarcoma, HTB‐9 bladder cancer, A549 lung cancer, and BEAS‐2B normal epithelial cell lines. Cells were treated with Luteolin (5–200 µM) alone or in combination with Cisplatin IC50 concentrations for 24–48 h, and cell viability was assessed using the WST‐1 assay. Co‐treatment with Luteolin significantly enhanced Cisplatin‐induced growth inhibition in cancer cells while exerting limited cytotoxicity in normal cells. Luteolin alone also demonstrated concentration‐dependent antiproliferative activity. In conclusion, Luteolin exerted marked hepatorenal protective effects and enhanced the antiproliferative activity of Cisplatin in experimental models. These findings suggest that Luteolin may represent a promising adjunctive candidate for reducing Cisplatin‐associated toxicity while improving therapeutic responsiveness.

Read PDF

Similar papers

Open access Sep 2026

Physiological evaluation of the role of curcumin and black seed oil in reducing carboplatin-induced toxicity in Swiss albino mice

Carboplatin is a potent platinum-based chemotherapeutic, but its clinical use is limited due to serious toxicities, including hepatotoxicity and nephrotoxicity, which are associated with oxidative stress. This study evaluated the protective effects of curcumin and black seed oil against carboplatin-induced toxicity. Tw...

A. H. Alhamadani, Doaa Fareed Fawzi, Kadhim Sattar Al-Ali · 0 citations
Open access Sep 2026

Protective effects of vitamin E and vitamin C against cisplatin nephrotoxicity in female Wister rats

Cisplatin (CP) is a potent anticancer agent used in cancer treatment. However, Cisplatin had ability to induce multiorgan toxicity including nephrotoxicity. This study aims to investigate the effect of vitamin E (Vit. E) and Vitamin C (vit. C) on nephrotoxicity induced by cisplatin in female rats. Twenty Female white...

N. A. Al-Murshedy, Hutheyfa A. Al Salih, Nuha Qays Abdulmajeed et al. · 0 citations
2026

Hesperidin attenuates cisplatin-induced cardiotoxicity in rats through regulating autophagy

Objective: Cisplatin is a well-known anticancer drug whose use has been limited due to a variety of side effects. Evidence has confirmed that cisplatin consumption is associated with cardiac toxicity. Unfortunately, no drug has yet been found to treat cardiac toxicity or reduce the side effects caused by cisplatin. How...

Hoori Heidari Kahkesh, Negin Amini, Mohammad Badavi et al. · 0 citations
Open access Aug 2026

Protective Effects of Nebivolol Against Cisplatin-Induced Nephrotoxicity: An Experimental Study

Nebivolol can ameliorate CIN in rats, as demonstrated by improvements in several renal functional, oxidative-stress, inflammatory, and histopathological outcomes, which support the nephroprotective potential of nebivolol but warrant confirmation in further preclinical studies.

Jamal J. Omer, D. Ibrahim, Mogahed A. Al-Shawia et al. · 0 citations
Open access Sep 2026

Comparative Protective Effects of Khaya grandifoliola CDC and Zingiber officinale against Cisplatin Induced Hepatic and Renal Toxicity through Antioxidant Mechanisms

Both plant extracts exert significant hepato- and nephroprotective effects against cisplatin-induced toxicity, likely through antioxidant and cytoprotective mechanisms, and support their potential use as complementary agents to mitigate chemotherapy-induced organ toxicity and prevent weight loss.

Danielle Yaba Ambassa, Charnelle Fokoua Bakam, B. E. Enang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.